UPI Insider Trading Activity and SEC Form 4 Filings
UPI insider trading summary
No open-market insider purchases or sales of Uroplasty Inc (UPI) have been reported on SEC Form 4 in the past 12 months.
Latest UPI insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Jan 30, 2015 | Brett Reynolds | Senior Vice President and CFO | Buy | $396 (300 @ $1.32) |
| Jan 30, 2015 | Brett Reynolds | Senior Vice President and CFO | Buy | $5K (3,500 @ $1.32) |
| Jan 30, 2015 | Brett Reynolds | Senior Vice President and CFO | Buy | $2K (1,200 @ $1.31) |
| Jan 29, 2015 | Robert Kill | President and CEO | Buy | $21K (16,250 @ $1.28) |
| Jan 29, 2015 | Kevin H Roche | Director | Buy | $1K (1,100 @ $1.24) |
| Jan 29, 2015 | Kevin H Roche | Director | Buy | $21K (16,800 @ $1.25) |
| Jan 29, 2015 | Kevin H Roche | Director | Buy | $9K (7,100 @ $1.23) |
| Jan 29, 2015 | Kevin H Roche | Director | Buy | $30K (25,000 @ $1.21) |
| Jan 29, 2015 | Robert Kill | President and CEO | Buy | $8K (6,150 @ $1.23) |
| Jan 29, 2015 | Robert Kill | President and CEO | Buy | $3K (2,500 @ $1.23) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.